Literature DB >> 30579884

Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems.

M R Arnold1, P H Williams2, J A McArthur3, A R Archuleta4, C E O'Neill5, J E Hassell6, D G Smith7, R K Bachtell8, C A Lowry9.   

Abstract

Caffeine is the most commonly used drug in the world. However, animal studies suggest that chronic consumption of caffeine during adolescence can result in enhanced anxiety-like behavioral responses during adulthood. One mechanism through which chronic caffeine administration may influence subsequent anxiety-like responses is through actions on brainstem serotonergic systems. In order to explore potential effects of chronic caffeine consumption on brainstem serotonergic systems, we evaluated the effects of a 28-day exposure to chronic caffeine (0.3 g/L; postnatal day 28-56) or vehicle administration in the drinking water, followed by 24 h caffeine withdrawal, and subsequent challenge with caffeine (30 mg/kg; s.c.) or vehicle in adolescent male rats. In Experiment 1, acute caffeine challenge induced a widespread activation of serotonergic neurons throughout the dorsal raphe nucleus (DR); this effect was attenuated in rats that had been exposed to chronic caffeine consumption. In Experiment 2, acute caffeine administration profoundly decreased tph2 and slc22a3 mRNA expression throughout the DR, with no effects on htr1a or slc6a4 mRNA expression. Chronic caffeine exposure for four weeks during adolescence was sufficient to decrease tph2 mRNA expression in the DR measured 28 h after caffeine withdrawal. Chronic caffeine administration during adolescence did not impact the ability of acute caffeine to decrease tph2 or slc22a3 mRNA expression. Together, these data suggest that both chronic caffeine administration during adolescence and acute caffeine challenge during adulthood are important determinants of serotonergic function and serotonergic gene expression, effects that may contribute to chronic effects of caffeine on anxiety-like responses.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30579884      PMCID: PMC6438184          DOI: 10.1016/j.neuropharm.2018.12.019

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  107 in total

1.  Modulation of the hypothalamo-pituitary-adrenocortical axis by caffeine.

Authors:  Michael D Patz; Heidi E W Day; Andrew Burow; Serge Campeau
Journal:  Psychoneuroendocrinology       Date:  2006-01-04       Impact factor: 4.905

2.  Central c-Fos expression in neonatal and adult rats after subcutaneous injection of hypertonic saline.

Authors:  L Rinaman; E M Stricker; G E Hoffman; J G Verbalis
Journal:  Neuroscience       Date:  1997-08       Impact factor: 3.590

3.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

4.  Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus.

Authors:  Daniel R Staub; Francesca Spiga; Christopher A Lowry
Journal:  Brain Res       Date:  2005-04-15       Impact factor: 3.252

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry.

Authors:  N Singewald; T Sharp
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

Review 7.  Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.

Authors:  Andrew K Evans; Christopher A Lowry
Journal:  CNS Drug Rev       Date:  2007

8.  Lipopolysaccharide has indomethacin-sensitive actions on Fos expression in topographically organized subpopulations of serotonergic neurons.

Authors:  Jacob H Hollis; Andrew K Evans; Kimberly P E Bruce; Stafford L Lightman; Christopher A Lowry
Journal:  Brain Behav Immun       Date:  2006-03-22       Impact factor: 7.217

9.  Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage.

Authors:  Olga Björklund; Mingmei Shang; Ilaria Tonazzini; Elisabetta Daré; Bertil B Fredholm
Journal:  Eur J Pharmacol       Date:  2008-08-13       Impact factor: 4.432

10.  Two models of inescapable stress increase tph2 mRNA expression in the anxiety-related dorsomedial part of the dorsal raphe nucleus.

Authors:  Nina C Donner; Kenneth H Kubala; James E Hassell; Margaret W Lieb; Kadi T Nguyen; Jared D Heinze; Robert C Drugan; Steven F Maier; Christopher A Lowry
Journal:  Neurobiol Stress       Date:  2018-01-17
View more
  1 in total

Review 1.  The Good, the Bad, and the Deadly: Adenosinergic Mechanisms Underlying Sudden Unexpected Death in Epilepsy.

Authors:  Benton Purnell; Madhuvika Murugan; Raja Jani; Detlev Boison
Journal:  Front Neurosci       Date:  2021-07-12       Impact factor: 4.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.